[go: up one dir, main page]

WO1997019178A3 - Proteases metalliques autoantigenes et procedes permettant de diagnostiquer des maladies auto-immunes - Google Patents

Proteases metalliques autoantigenes et procedes permettant de diagnostiquer des maladies auto-immunes Download PDF

Info

Publication number
WO1997019178A3
WO1997019178A3 PCT/DE1996/002094 DE9602094W WO9719178A3 WO 1997019178 A3 WO1997019178 A3 WO 1997019178A3 DE 9602094 W DE9602094 W DE 9602094W WO 9719178 A3 WO9719178 A3 WO 9719178A3
Authority
WO
WIPO (PCT)
Prior art keywords
autoantigenic
polypeptide
autoimmune diseases
methods
diagnosing autoimmune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1996/002094
Other languages
German (de)
English (en)
Other versions
WO1997019178A2 (fr
Inventor
Ulrich Krawinkel
Simon Mauch
Radislav Sedlacek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Konstanz
Original Assignee
Universitaet Konstanz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Konstanz filed Critical Universitaet Konstanz
Publication of WO1997019178A2 publication Critical patent/WO1997019178A2/fr
Publication of WO1997019178A3 publication Critical patent/WO1997019178A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des acides nucléiques, qui contiennent au moins une séquence d'acide nucléique codant un polypeptide. Le polypeptide contient au moins un déterminant autoantigénique issu d'une protéase métallique. L'invention concerne également ledit polypeptide, des anticorps dirigés contre le polypeptide et des inhibiteurs spécifiques dirigés contre le polypeptide. L'invention concerne en outre des procédés et des nécessaires permettant de détecter la présence de protéases métalliques autoantigéniques et de maladies auto-immunes telles que l'arthrite rhumatoïde.
PCT/DE1996/002094 1995-11-20 1996-11-04 Proteases metalliques autoantigenes et procedes permettant de diagnostiquer des maladies auto-immunes Ceased WO1997019178A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19543265A DE19543265A1 (de) 1995-11-20 1995-11-20 Autoantigene und Verfahren zur Diagnose von Autoimmunkrankheiten
DE19543265.7 1995-11-20

Publications (2)

Publication Number Publication Date
WO1997019178A2 WO1997019178A2 (fr) 1997-05-29
WO1997019178A3 true WO1997019178A3 (fr) 1997-09-25

Family

ID=7777951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/002094 Ceased WO1997019178A2 (fr) 1995-11-20 1996-11-04 Proteases metalliques autoantigenes et procedes permettant de diagnostiquer des maladies auto-immunes

Country Status (2)

Country Link
DE (1) DE19543265A1 (fr)
WO (1) WO1997019178A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897426B1 (fr) 1996-04-25 2006-06-28 Takeda Pharmaceutical Company Limited Metalloprotease matricielle
WO1998040475A1 (fr) * 1997-03-11 1998-09-17 Abbott Laboratories Gene humain de metalloprotease matricielle, proteines codees a partir de ce dernier, et procedes d'utilisation associes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0522169A1 (fr) * 1991-01-21 1993-01-13 Fuji Yakuhin Kogyo Kabushiki Kaisha Anticorps monoclonal anti-stromelysine humaine et diagnostic de l'arthrite rhumato de par immunoanalyse enzymatique
WO1994010208A1 (fr) * 1992-10-29 1994-05-11 Miles Inc. Titrage a des fins de diagnostic servant a rechercher la metalloproteinase a matrice latente no. 9

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69412466T2 (de) * 1993-11-30 1999-04-29 Fuji Yakuhin Kogyo K.K., Takaoka, Toyama Neue metalloprotease und kodierende dna dafür
EP0750672B1 (fr) * 1994-03-17 2001-11-28 Max-Delbrück-Centrum Für Molekulare Medizin Sequences d'adn pour metalloproteases matricielles, leur production et leur utilisation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0522169A1 (fr) * 1991-01-21 1993-01-13 Fuji Yakuhin Kogyo Kabushiki Kaisha Anticorps monoclonal anti-stromelysine humaine et diagnostic de l'arthrite rhumato de par immunoanalyse enzymatique
WO1994010208A1 (fr) * 1992-10-29 1994-05-11 Miles Inc. Titrage a des fins de diagnostic servant a rechercher la metalloproteinase a matrice latente no. 9

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COSSINS J ET AL: "Identification of MMP-18, a putative novel human matrix metalloproteinase.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 228 (2). 1996. 494-498. ISSN: 0006-291X, XP002036483 *
SIRUM K L ET AL: "CLONING OF THE GENES FOR HUMAN STROMELYSIN AND STROMELYSIN 2: DIFFERENTIAL EXPRESSION IN RHEUMATOID SYNOVIAL FIBROBLASTS", BIOCHEMISTRY, vol. 28, no. 22, 1989, pages 8691 - 8698, XP002029122 *

Also Published As

Publication number Publication date
DE19543265A1 (de) 1997-06-05
WO1997019178A2 (fr) 1997-05-29

Similar Documents

Publication Publication Date Title
EP0621284A4 (fr) PEPTIDES CONTENANT DES SEQUENCES D'ACIDES AMINES RESPECTIVES SELECTIONNEES PARMI CELLES DE LA LIPOPROTEINE(a) ET DE L'APOLIPOPROTEINE(a), ANTICORPS RECONNAISSANT CES SEQUENCES D'ACIDES AMINES ET PROCEDE D'ANALYSE UTILISANT CES ANTICORPS.
WO2003050542A3 (fr) Procede pour detecter des auto-anticorps chez des patients souffrant de polyarthrite rhumatoide, peptide et trousse de dosage
WO1999047656A3 (fr) Proteines de fixation a l'acide nucleique
CA2248140A1 (fr) Analyses et reactifs permettant de quantifier le hbnp
IL163066A (en) Ligands for the zcytor17 receptor
CA2344642A1 (fr) Caracterisation de polypeptides par clivage et spectrometrie de masse
WO1999057311A3 (fr) Nouveau procede permettant l'identification de clones conferant une propriete biologique desiree dans une banque d'expression
WO1998022503A3 (fr) Peptide derive d'un antigene reconnu par des auto-anticorps provenant de patients souffrant de polyarthrite rhumatoide, anticorps dirige contre ce peptide, antigene combinatoire et procede de detection d'anticorps auto-immuns
AU1061597A (en) Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders
CA2090126A1 (fr) Methodes de production de proteines dotees d'une fonction desiree
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
EP0630974A3 (fr) Procédé et housse d'essai de détection d'orthophosphate inorganique dans l'amplification d'acides nucléiques cibles.
WO1998021333A3 (fr) Acide nucleique codant des proteines de fixation de la schwannomine et produits associes
WO2002031509A3 (fr) Methode de determination d'un fragment d'alteration de masse des peptide
WO1998042827A3 (fr) Gene codant pour un oxalate decarboxylase isole a partir d'aspergillus phoenices
EP0253325A3 (fr) Peptides, relatifs aux oncogènes
WO1997019178A3 (fr) Proteases metalliques autoantigenes et procedes permettant de diagnostiquer des maladies auto-immunes
CA2129044A1 (fr) Determination des affinites de liaison a l'aide d'elements liants a identification magnetique
AU2284997A (en) Marker for male infertility and/or fertility
EP1342729A3 (fr) Anticorps et molécules antisense pour récepteur couplé à la protéine G avec affinité sélective pour l'ATP
WO1994024283A3 (fr) Proteine mammalienne de liaison des nucleotides de guanine presentant un domaine facteur de rybosylation d'adp
WO1996040763A3 (fr) Peptides destines a la detection du vih-1
WO1999012033A3 (fr) Procede et kit pour identifier des interactions entre des proteines ou des peptides
WO1998030687A3 (fr) Proteine contenant un domaine srcr

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA GB JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97519273

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase